RAPGEF4 and Alzheimer disease: Modulation of cyclic adenosine monophosphate (cAMP)/exchange factor directly activated by the cAMP 2 (Epac2) pathway could be a strategy to enhance synaptic plasticity and thereby improve memory deficits in AD.